Table 3.
The mean values of the sarcopenia marker variables, the frequency of sarcopenic individuals for each variable and the prevalence of sarcopenia according to the EWGSOP2 diagnostic algorithm. n = 60. Data presented as mean ± SD or n (%).
| Individual Criterion | Value for Criterion | Consistent with Sarcopenia, n (%) | Diagnostic Algorithm | Consistent with Sarcopenia, n (%) |
|---|---|---|---|---|
| Find | ||||
| SARC-F (points) | 2.6 ± 2.3 | 18 (30%) | ||
| Assess: Probable sarcopenia | ||||
| GSD (Kg) | 19.2 ± 6.6 | 45 (75%) | GSD | 45 (75%) |
| STS5 (s) | 20.3 ± 6.3 | 53 (88%) | STS-5 | 53 (88%) |
| GSD and/or STS-5 | 58 (97%) | |||
| Confirm: Sarcopenia confirmed | ||||
| ASM (kg) | 19.3 ± 3.8 | 24 (40%) | GSD + ASM | 23 (38%) |
| STS-5 + ASM | 22 (37%) | |||
| GSD and/or STS-5 + ASM | 24 (40%) | |||
| Severity: Severe sarcopenia | ||||
| GS (m/s) | 0.69 ± 0.27 | 42 (70%) | GSD + ASM + GS | 19 (32%) |
| STS-5 + ASM + GS | 19 (32%) | |||
| GSD and/or STS-5 + ASM + GS | 19 (32%) | |||
| TUG (s) | 19.1 ± 12.1 | 22 (37%) | GSD + ASM + TUG | 11 (18%) |
| STS-5 + ASM + TUG | 11 (18%) | |||
| GSD and/or STS5 +ASM + TUG | 11 (18%) | |||
| SPPB (points) | 6.2 ± 2.9 | 45 (75%) | GSD + ASM + SPPB | 21 (35%) |
| STS-5 + ASM + SPPB | 21 (35%) | |||
| GSD and/or STS-5 + ASM + SPPB | 21 (35%) | |||
| GSD and/or STS-5 + ASM + GS and/or TUG and/or SPPB | 22 (37%) | |||
SARC-F: Strength, Assistance walking, Rise from a chair, Climb stairs, and Falls; GSD: grip strength by dynamometry, STS-5: sit to stand to sit 5, ASM: appendicular skeletal muscle mass, GS: gait speed, TUG: Timed-Up and Go test, SPPB: Short Physical Performance Battery. Variables used in the mortality analysis are marked in orange.